EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stigmasterol Protects Against Dexamethasone-Induced Muscle Atrophy by Modulating the FoxO3–MuRF1/MAFbx Signaling Pathway in C2C12 Myotubes and Mouse Skeletal Muscle

Young-Sool Hah iD, Seung-Jun Lee iD, Yeung-Ho Ji iD, Jeongyun Hwang iD, Han-Gil Kim iD, Young-Tae Ju iD, Jun-Il Yoo iD, Seung-Jin Kwag iD

Biomolecules · 2025

DOI: 10.3390/biom15111551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Young-Sool Hah und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Institute of Medical Science, Gyeongsang National University College of Medicine and Gyeongsang National University Hospital, …. Hauptthemen laut MEDLINE: Muscular Atrophy, Forkhead Box Protein O3, Muscle Fibers, Skeletal, Stigmasterol. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) grant funded by the Korean government, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucocorticoid therapy, using agents like dexamethasone (Dexa), often leads to muscle atrophy by increasing protein degradation via the ubiquitin–proteasome system while suppressing protein synthesis. Stigmasterol, a phytosterol with known bioactivities, has an unexplored role in muscle atrophy. This study investigated stigmasterol’s protective effects against Dexa-induced muscle atrophy and its impact on the FoxO3 and mTORC1 signaling pathways. Differentiated C2C12 myotubes were treated with Dexa (50 µM) ± stigmasterol (10 µM), and the morphology, viability, and protein levels in the FoxO3/MuRF1/MAFbx catabolic and mTOR/p70S6K/4E-BP1 anabolic signaling pathways were assessed. C57BL/6 mice received Dexa (20 mg/kg/day i.p.) ± stigmasterol (3 mg/kg/day oral) for 21 days, and the body/muscle mass, bone mineral density (BMD), fiber cross-sectional area (CSA), and muscle protein expression were measured. Stigmasterol (10 µM) was non-toxic and attenuated Dexa-induced reductions in myotube diameter and fusion in vitro, concurrent with suppressing Dexa-induced upregulation of FoxO3/MuRF1/MAFbx proteins and preventing the Dexa-induced dephosphorylation of mTOR/p70S6K/4E-BP1 proteins. In vivo, stigmasterol mitigated Dexa-induced losses in body weight, muscle mass, BMD, and fiber CSA. This protection was associated with attenuated upregulation of FoxO3 and MAFbx proteins in muscle tissue. Stigmasterol protected against Dexa-induced muscle atrophy in vitro and in vivo via modulation of the FoxO3–MAFbx catabolic pathway. These findings suggest stigmasterol inhibits excessive glucocorticoid-induced muscle protein breakdown. It therefore warrants further investigation as a potential therapeutic agent for glucocorticoid myopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular AtrophyForkhead Box Protein O3Muscle Fibers, SkeletalStigmasterolDexamethasoneSignal TransductionMuscle ProteinsUbiquitin-Protein LigasesMuscle, SkeletalTripartite Motif ProteinsSKP Cullin F-Box Protein LigasesAnimalsMiceMice, Inbred C57BLMaleCell Line

Stichwörter der Autor:innen

4E-BP1C2C12FoxO3MAFbxMuRF1dexamethasonemTORmuscle atrophyp70S6Kphytosterolprotein synthesisstigmasterolubiquitin–proteasome system

Substanzen

Forkhead Box Protein O3StigmasterolDexamethasoneFoxO3 protein, mouseMuscle ProteinsTrim63 protein, mouseUbiquitin-Protein LigasesTripartite Motif ProteinsFbxo32 protein, mouseSKP Cullin F-Box Protein Ligases

Autor:innen und Institutionen

  • Department of Surgery, Institute of Medical Science, Gyeongsang National University College of Medicine and Gyeongsang National University Hospital, Jinju 52727, Republic of Korea.
  • Biomedical Research Institute, Gyeongsang National University Hospital, Jinju 52727, Republic of Korea.
  • Department of Convergence Medical Sciences, Gyeongsang National University, Jinju 52725, Republic of Korea.
  • Department of Orthopaedic Surgery, Inha University Hospital, Inha University School of Medicine, Incheon 22332, Republic of Korea.

ORCID-Profile: Young-Sool Hah, Seung-Jun Lee, Yeung-Ho Ji, Jeongyun Hwang, Han-Gil Kim, Young-Tae Ju, Jun-Il Yoo, Seung-Jin Kwag

Förderung

  • National Research Foundation of Korea (NRF) grant funded by the Korean government
  • National Research Foundation of Korea

Zitieren

APA

Hah, Y. S., Lee, S. J., Ji, Y. H., Hwang, J., Kim, H. G., Ju, Y. T., Yoo, J. I., & Kwag, S. J. (2025). Stigmasterol Protects Against Dexamethasone-Induced Muscle Atrophy by Modulating the FoxO3–MuRF1/MAFbx Signaling Pathway in C2C12 Myotubes and Mouse Skeletal Muscle. Biomolecules. https://doi.org/10.3390/biom15111551

Vancouver

Hah YS, Lee SJ, Ji YH, Hwang J, Kim HG, Ju YT, et al. Stigmasterol Protects Against Dexamethasone-Induced Muscle Atrophy by Modulating the FoxO3–MuRF1/MAFbx Signaling Pathway in C2C12 Myotubes and Mouse Skeletal Muscle. Biomolecules. 2025. doi:10.3390/biom15111551

BibTeX
@article{Hah2025,
  author = {Hah, Young-Sool and Lee, Seung-Jun and Ji, Yeung-Ho and Hwang, Jeongyun and Kim, Han-Gil and Ju, Young-Tae and Yoo, Jun-Il and Kwag, Seung-Jin},
  title = {Stigmasterol Protects Against Dexamethasone-Induced Muscle Atrophy by Modulating the FoxO3–MuRF1/MAFbx Signaling Pathway in C2C12 Myotubes and Mouse Skeletal Muscle},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15111551}
}
Kostenlos starten →